Ischemia–reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function
Open accessAbstract
Reperfusion injury following ischemic stroke is a complex pathophysiological process involving numerous mechanisms ranging from the release of excitatory amino acids and ion disequilibrium to the induction of apoptosis and necrosis, to oxidative stress and inflammation. The migration of neutrophils into the brain parenchyma and release of their abundant proteases are generally considered the main cause of neuronal cell death and acute reperfusion injury following ischemic stroke. Recent findings in experimental and human stroke have challenged this view, as the majority of neutrophils were rather found to accumulate within the neurovascular unit (NVU) and the subarachnoid space (SAS) where they remain separated from the brain parenchyma by the glia limitans. The brain parenchyma is an immune-privileged site that is not readily accessible to immune cells and does not elicit stereotypic adaptive or innate immune responses. Understanding brain immune privilege requires intimate knowledge of its unique anatomy in which the brain barriers, that include the glia limitans, establish compartments that differ remarkably with regard to their accessibility to the immune system. We here propose that the brain immune privilege also extends to an ischemic insult, where the brain parenchyma does not evoke a rapid infiltration of neutrophils as observed in ischemic events in peripheral organs. Rather, neutrophil accumulation in the NVU and SAS could have a potential impact on cerebrospinal fluid (CSF) drainage from the central nervous system (CNS) and thus on edema formation and reperfusion injury after ischemic stroke. Integrating the anatomical and functional implications of the brain immune privilege with the unquestionable role of neutrophils in reperfusion injury is a prerequisite to exploit appropriate strategies for therapeutic interventions aiming to reduce neuronal cell death after ischemic stroke.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
After cerebral ischemia or subarachnoid hemorrhage, neutrophils rapidly accumulate in the leptomeningeal space.
“After cerebral ischemia or subarachnoid hemorrhage, neutrophils rapidly accumulate in the leptomeningeal space (142).”
From The anatomy and immunology of vasculature in the central nervous system (2019) · cites this paper as [142]
A number of preclinical and clinical trials have failed to improve ischemic stroke outcomes or lesion size by preventing leukocyte diapedesis, indicating that our knowledge of the inflammatory response to this condition is incomplete.
“To date, a number of preclinical and clinical trials have failed to improve ischemic stroke outcomes or lesion size by preventing leukocyte diapedesis (142, 147), indicating that our knowledge of the inflammatory response to this condition is incomplete.”
From The anatomy and immunology of vasculature in the central nervous system (2019) · cites this paper as [142]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 118 · Cited by 119
Research works printed but not linked: 1
- [116]Hannocks MJ Pizzo ME Huppert J et al Molecular characterization of perivascular drainage pathways in the murine brain. J Cereb Blood Flow Metab 2018; 38: 669– 686. 29283289 PMC5888861
- Authors
- Enzmann, G., Kargaran, S., & Engelhardt, B.
- Affiliations
- University of Bern (CH)
- Corresponding author
- Engelhardt, Britta
- ORCID
- Engelhardt, Britta
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2018-01
- Volume
- 11
- Pages
- 1756286418794184-1756286418794184
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- PMC
- PMC6111395
- OpenAlex
- W2888938950
- Cited by
- 119
- References
- 118
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 11 · 2023: 20 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 7
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Therapeutic Advances in Neurological Disorders (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Open Access CRIS of the University of Bern
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- ischemia-reperfusion injury, ischemic stroke, neutrophils, brain barriers, glia limitans, neurovascular unit, subarachnoid space, cerebrospinal fluid drainage, cerebral edema, neutrophil migration, oxidative stress, inflammation, neuronal cell death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review